Elephas Raises $40M in Series B-2 Funding

The Wisconsin-based startup Elephas last week received USD 40 million in Series B-2 financing led by Northpond Ventures, with participation from ARCH Venture Partners, the State of Wisconsin Investment Board, Tao Capital Partners, Sands Capital, and Venture Investors Health Fund, among others.

Founded in 2020 by Maneesh Arora, Elephas focuses on simulating, through complex algorithms, the response of cancerous tumors to different immunotherapy treatments, with the goal of predicting how the tumor will respond within 72 hours.

Its main product is Elephas Live Platform, which operates in three stages: Prepare, Assess, and Result. Together, these three phases evaluate preservation, response, and outcomes of the treatments applied to biopsies.

With this financing, the company expects to launch and commercialize its product as a laboratory-developed test (LDT) and, in doing so, achieve greater clinical validation that will allow it to scale in the market.

Founder: Maneesh Arora

Sources: Crunchbase | Elephas